Mingcheng at Nature Conference of Engineered Models of Human Disease

On 28 October 2025, Mingcheng gave an oral presentation on his research at the Nature Conference on Engineered Models of Human Disease, held in Serbia. The conference brought together international experts in bioengineering, artificial intelligence, and translational medicine to discuss emerging technologies that bridge computational and experimental models of human disease.

Mingcheng’s presentation, titled “Leveraging ICU-derived LLM evidence to design and validate liver organoid-on-chip models for drug-induced injury,” explored the powerful synergy between artificial intelligence for healthcare and organoid models. His work uses large language models (LLMs) to extract clinically relevant evidence from intensive care unit (ICU) patient records, enabling the design of organoid-on-chip models that more accurately replicate complex clinical conditions. These high-fidelity organoid systems have the potential to provide an in-vitro validation platform for clinical AI, helping to improve model reliability and safety before translation to human trials.